Is it safe?
Can AMGN take a bad year?
Amgen carries $43.3B of net debt at 3.07× EBITDA: a load its earnings can carry.
$43.3B
Net debt · as at Q2 2026 · between two and four years of EBITDA, normal for a stable business
- Net debt / EBITDA
- 3.07×
Net debt / EBITDA · 4.23× a year ago · the load is coming down
- Altman Z-score
- 1.79
Altman Z-score · distress zone, below 1.8
- Interest cover
- 4.28×
Interest cover · operating profit covers the interest bill, with room to spare
Details›
- Total debtQ2 2026
- $57.3B
- Cash and short-term investments
- $14.0B
- Net debt
- $43.3B
- EBITDA, trailing twelve months
- $14.1B
- Operating profit, trailing twelve months
- $11.4B
- Debt / equity
- 4.90×
- Total debt / EBITDA
- 4.06×
- Annualised volatilitytwo years of daily moves
- 28%
- Worst drawdown on file
- −25%
- Below its 52-week high
- −0.78%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers - General
Ranks #5 of 16 by Smart Score